Tumor website：www.tumorsci.org E-mail Alert
Antivascular therapy after recurrence of glioblastoma: anlotinib vs bevacizumab
ZHOU Jin, LIU Haoyun, ZHANG Haoyu, YANG Xinyue, WANG Ruizhi, HUANG Renhua
Tumor . 2024, (09): 971 -978 .  DOI: 10.3781/j.issn.1000-7431.2024.2402-0089

Copyright © Tumor, All Rights Reserved.
E-mail: tumor@tumorsci.org
Powered by Beijing Magtech Co., Ltd.